Articles & Reports Archive - Page 9 of 333 - The Source on HealthCare Price and Competition

Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018

March 17, 2020

Promoting Biosimilar Competition to Reduce Patients’ Out-of-Pocket Costs

March 17, 2020

Potential costs of coronavirus treatment for people with employer coverage

March 13, 2020

A Proposal to Cap Provider Prices and Price Growth in the Commercial Health-Care Market

March 10, 2020

Health Care Payments Data Program: Report to the Legislature

March 9, 2020

Promoting Health Care Transparency via State Legislative Efforts

March 9, 2020

Price Transparency: Empowering Patient Choice and Promoting Provider Competition

March 5, 2020

The Evolution and Impact of Hospital Price Transparency in North Carolina

March 5, 2020

How the Massachusetts Health Policy Commission Is Fostering a Statewide Commitment to Contain Health Care Spending Growth

March 5, 2020

The Impact of Acquisitions on Clinical Decisions: Evidence from Physician Practice Management Companies

March 3, 2020

Did the Affordable Care Act Lower Financial Barriers to Health Care?

March 3, 2020

A Pathway To Consumer-Driven Universal Coverage

March 2, 2020

The ACA And The Courts: Litigation’s Effects On The Law’s Implementation And Beyond

March 2, 2020

How The ACA Reframed The Prescription Drug Market And Set The Stage For Current Reform Efforts

March 2, 2020

Building On The Gains Of The ACA: Federal Proposals To Improve Coverage And Affordability

March 2, 2020

Report of the Minnesota Attorney General’s Advisory Task Force on Lowering Pharmaceutical Drug Prices

February 27, 2020